Mallinckrodt plc to Report Third Quarter Results on August 9, 2013
DUBLIN--(BUSINESS WIRE)--Jul. 9, 2013--
Mallinckrodt plc (NYSE: MNK) will report third quarter results on August
9, 2013, before trading opens for the day on the New York Stock
Exchange. The company will hold a conference call for investors
beginning at 8:30am/U.S. Eastern Daylight Time. The call can be accessed
in three ways.
At the Mallinckrodt website: http://mallinckrodt.com/investor_relations.aspx
By telephone: For both “listen-only” participants and those who wish
to take part in the question-and-answer portion of the call, the
telephone dial-in number in the U.S. is 877-415- 3182. For
participants outside the U.S., the dial-in number is 857-244-7325. The
access code for all callers is 44964726.
Through an audio replay: A replay of the call will be available
beginning at 10:30am/ U.S. Eastern Daylight Time on August 9, 2013,
and ending at 11:59pm/ U.S. Eastern Daylight Time on August 23, 2013.
The dial-in number for U.S. participants is 888-286-8010. For
participants outside the U.S., the replay dial-in number is 617-
801-6888. The replay access code for all callers is 51646528.
Mallinckrodt is a leading global specialty pharmaceuticals business that
develops, manufactures, markets and distributes specialty pharmaceutical
products and medical imaging agents with the highest quality standards
and care. The company’s Specialty Pharmaceuticals segment includes
branded and generic drugs, and the Global Medical Imaging segment
includes contrast media and nuclear imaging agents. Mallinckrodt has
approximately 5,500 employees worldwide with direct sales in roughly 50
countries and distribution in approximately 40 countries. The company’s
2012 revenue totaled $2.1 billion. To learn more about Mallinckrodt,
Source: Mallinckrodt plc
John Moten, 314-654-6650
Manager, Media Relations
Senior Vice President, Communications